UY32299A - Composiciones farmacéuticas líquidas - Google Patents

Composiciones farmacéuticas líquidas

Info

Publication number
UY32299A
UY32299A UY0001032299A UY32299A UY32299A UY 32299 A UY32299 A UY 32299A UY 0001032299 A UY0001032299 A UY 0001032299A UY 32299 A UY32299 A UY 32299A UY 32299 A UY32299 A UY 32299A
Authority
UY
Uruguay
Prior art keywords
liquid pharmaceutical
pharmaceutical compositions
xylitol
hydrates
salts
Prior art date
Application number
UY0001032299A
Other languages
English (en)
Inventor
Masso Carbonell Antoni
Guiro Coll Pere
Duarte Lopez Begona
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of UY32299A publication Critical patent/UY32299A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición farmacéutica líquida acuosa que comprende a) al menos un compuestos de triptán, sales o hidratos de los mismos farmacéuticamente aceptables, y b) xilitol
UY0001032299A 2008-12-22 2009-12-04 Composiciones farmacéuticas líquidas UY32299A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08382083A EP2198889A1 (en) 2008-12-22 2008-12-22 Liquid pharmaceutical compositions comprising a triptan compound and Xylitol

Publications (1)

Publication Number Publication Date
UY32299A true UY32299A (es) 2010-05-31

Family

ID=40749242

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032299A UY32299A (es) 2008-12-22 2009-12-04 Composiciones farmacéuticas líquidas

Country Status (11)

Country Link
US (1) US20110257228A1 (es)
EP (2) EP2198889A1 (es)
JP (1) JP2012513423A (es)
KR (1) KR20110116122A (es)
CN (1) CN102264395A (es)
AR (1) AR074793A1 (es)
CA (1) CA2748103A1 (es)
MX (1) MX2011006489A (es)
TW (1) TW201023913A (es)
UY (1) UY32299A (es)
WO (1) WO2010072353A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5776355B2 (ja) * 2010-07-16 2015-09-09 大正製薬株式会社 内服液剤
JP5887893B2 (ja) * 2010-12-10 2016-03-16 大正製薬株式会社 内服液剤
JP5887894B2 (ja) * 2010-12-10 2016-03-16 大正製薬株式会社 内服液剤
KR101695071B1 (ko) * 2014-12-26 2017-01-11 연세대학교 산학협력단 액상으로 약물을 분산시킨 필름형태의 약제학적 조성물
JP6803250B2 (ja) * 2017-02-02 2020-12-23 共和薬品工業株式会社 エレトリプタン臭化水素酸塩含有口腔内崩壊錠
IT201700099690A1 (it) * 2017-09-06 2019-03-06 Abiogen Pharma Spa Composizione per l’integrazione di calcio
EP3863626A1 (en) 2018-10-09 2021-08-18 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Oral liquid composition comprising triptan
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004266731A1 (en) * 2003-08-21 2005-03-03 Transoral Pharmaceuticals, Inc. Compositions for delivering 5-HT agonists across the oral mucosa and methods of use thereof
WO2007070504A2 (en) 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions

Also Published As

Publication number Publication date
EP2367573A1 (en) 2011-09-28
KR20110116122A (ko) 2011-10-25
MX2011006489A (es) 2011-07-13
AR074793A1 (es) 2011-02-09
US20110257228A1 (en) 2011-10-20
CN102264395A (zh) 2011-11-30
JP2012513423A (ja) 2012-06-14
EP2198889A1 (en) 2010-06-23
WO2010072353A1 (en) 2010-07-01
CA2748103A1 (en) 2010-07-01
TW201023913A (en) 2010-07-01

Similar Documents

Publication Publication Date Title
UY32299A (es) Composiciones farmacéuticas líquidas
CO6511251A2 (es) Compuestos quimicos
CL2008002538A1 (es) Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral
CL2008002539A1 (es) Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral
CL2011002697A1 (es) Compuestos derivados de 3-[4-(oxo-dihidropiridin)bencil]-1,3-oxazin-ona hidratados, inhibidores 11beta-hsd1; composicion farmaceutica que los comprende; y su uso en el tratamiento de la diabetes
CL2009000882A1 (es) Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer.
CO6321158A2 (es) Formulacion oral
CL2011001658A1 (es) Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor.
BRPI0809977A2 (pt) Uso de um composto, compostos e composição farmacêutica que o contém
PA8842201A1 (es) Inhibidores macrocíclicos de serina proteasas de hepatitis c
NI201000172A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad.
DK3103448T3 (da) Farmaceutiske sammensætninger, der omfatter en S1P-modulator
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
ECSP10010167A (es) Composiciones oftálmicas novedosas
UY33075A (es) Derivados de ciclohexano y usos de los mismos
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
AR088673A1 (es) Formulaciones de peliculas para los dientes
CL2009000914A1 (es) Compuestos derivados de 1-ciano-3-pirrolidinil-n-sustituidas-sulfonamidas, inhibidores de catepsina c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una enfermedad pulmonar obstructiva cronica.
UY30087A1 (es) Piperazinas y piperidinas como potenciadoras de mglur5
GT200600366A (es) Compuestos de imidazol sustituido como inhibidores de ksp
UY30163A1 (es) Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
ECSP099442A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
DOP2012000050A (es) Nuevas composiciones de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil] piperazina
CL2011003043A1 (es) Composicion para proteger sujeto contra serotipo de virus del dengue que comprende al menos dos serotipos de virus dengue; sistema para administrar una composicion de vacuna del dengue; kit de vacuna porque comprende al menos una composicion de vacuna contra el virus del dengue.